Howe & Rusling’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-54	Closed	-$1K	–	323
2022 Q3	$1K	Sell	54 -50	-48%	-$810	﹤0.01%	933
2022 Q2	$1K	Buy	104 +45	+76%	+$840	﹤0.01%	920
2022 Q1	$1K	Hold	59	–	–	﹤0.01%	907
2021 Q4	$1K	Sell	59 -39	-40%	-$784	﹤0.01%	901
2021 Q3	$2K	Buy	98 +33	+51%	+$636	﹤0.01%	826
2021 Q2	$2K	Hold	65	–	–	﹤0.01%	777
2021 Q1	$2K	Sell	65 -4,665	-99%	-$205K	﹤0.01%	777
2020 Q4	$253K	Hold	4,730	–	–	0.04%	150
2020 Q3	$195K	Hold	4,730	–	–	0.03%	152
2020 Q2	$229K	Hold	4,730	–	–	0.04%	127
2020 Q1	$200K	Buy	4,730 +1,900	+67%	+$78.3K	0.04%	139
2019 Q4	$121K	Hold	2,830	–	–	0.02%	223
2019 Q3	$102K	Hold	2,830	–	–	0.02%	238
2019 Q2	$76K	Hold	2,830	–	–	0.01%	259
2019 Q1	$76K	Hold	2,830	–	–	0.01%	251
2018 Q4	$46K	Hold	2,830	–	–	0.01%	266
2018 Q3	$59K	Hold	2,830	–	–	0.01%	251
2018 Q2	$43K	Hold	2,830	–	–	0.01%	270
2018 Q1	$64K	Hold	2,830	–	–	0.01%	254
2017 Q4	$85K	Hold	2,830	–	–	0.02%	250
2017 Q3	$107K	Hold	2,830	–	–	0.02%	237
2017 Q2	$79K	Buy	+2,830	New	+$84.3K	0.02%	225